• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞性哮喘患者的气消化道评估

Aerodigestive evaluation in patients with eosinophilic asthma.

作者信息

Citron Chloe, Erkman Jessica, Kazachkov Mikhail, Nowak-Wegrzyn Anna, Kesebir Deniz

机构信息

Department of Pediatrics, Hassenfeld Children's Hospital, NYU Grossman School of Medicine, NYU Langone Health, New York, USA.

Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.

出版信息

Respir Med Case Rep. 2025 Jun 30;57:102246. doi: 10.1016/j.rmcr.2025.102246. eCollection 2025.

DOI:10.1016/j.rmcr.2025.102246
PMID:40688717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12270745/
Abstract

We present two pediatric patients with severe uncontrolled asthma who underwent aerodigestive evaluation revealing eosinophilic asthma and eosinophilic esophageal inflammation. They were subsequently initiated on targeted biological therapy for eosinophilic inflammation with dupilumab resulting in clinical and histological improvement. These cases demonstrate that aerodigestive evaluation is an important clinical tool for characterizing asthma phenotypes and diagnosing comorbidities in children with SUA to optimize their treatment regimens.

摘要

我们报告了两名患有严重难治性哮喘的儿科患者,他们接受了气道消化道评估,结果显示为嗜酸性粒细胞性哮喘和嗜酸性粒细胞性食管炎。随后,他们开始接受针对嗜酸性粒细胞炎症的靶向生物治疗,使用度普利尤单抗,临床和组织学均有改善。这些病例表明,气道消化道评估是一种重要的临床工具,可用于明确重度未控制哮喘儿童的哮喘表型和诊断合并症,以优化其治疗方案。

相似文献

1
Aerodigestive evaluation in patients with eosinophilic asthma.嗜酸性粒细胞性哮喘患者的气消化道评估
Respir Med Case Rep. 2025 Jun 30;57:102246. doi: 10.1016/j.rmcr.2025.102246. eCollection 2025.
2
Anti-IL-5 therapies for asthma.哮喘的抗 IL-5 治疗。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD010834. doi: 10.1002/14651858.CD010834.pub4.
3
Anti-IL5 therapies for asthma.用于哮喘的抗白细胞介素-5疗法。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
4
Mepolizumab versus placebo for asthma.美泊利珠单抗对比安慰剂治疗哮喘
Cochrane Database Syst Rev. 2015 Jul 27(7):CD010834. doi: 10.1002/14651858.CD010834.pub2.
5
Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.抗白细胞介素-13 和抗白细胞介素-4 药物与安慰剂、抗白细胞介素-5 或抗免疫球蛋白 E 药物治疗哮喘患者的比较。
Cochrane Database Syst Rev. 2021 Oct 19;10(10):CD012929. doi: 10.1002/14651858.CD012929.pub2.
6
Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study.度普利尤单抗治疗嗜酸性食管炎儿童:一项回顾性多中心研究。
BMC Pediatr. 2025 Feb 5;25(1):100. doi: 10.1186/s12887-024-05313-w.
7
Systemic treatments for eczema: a network meta-analysis.湿疹的全身治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206. doi: 10.1002/14651858.CD013206.pub2.
8
Different oral corticosteroid regimens for acute asthma.用于急性哮喘的不同口服皮质类固醇治疗方案。
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD011801. doi: 10.1002/14651858.CD011801.pub2.
9
Vitamin C for asthma and exercise-induced bronchoconstriction.用于哮喘和运动诱发性支气管收缩的维生素C。
Cochrane Database Syst Rev. 2013 Oct 23;2013(10):CD010391. doi: 10.1002/14651858.CD010391.pub2.
10
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.

本文引用的文献

1
The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases.度普利尤单抗治疗中度至重度哮喘合并2型炎症性疾病儿童的评估。
BMC Pulm Med. 2024 Dec 16;24(1):607. doi: 10.1186/s12890-024-03414-x.
2
Epidemiology of severe asthma in children: a systematic review and meta-analysis.儿童严重哮喘的流行病学:系统评价和荟萃分析。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0095-2024. Print 2024 Oct.
3
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.度普利尤单抗可减少重度哮喘中糖皮质激素依赖患者的口服糖皮质激素使用:3 期、开放标签扩展 TRAVERSE 试验分析。
Chest. 2022 Jul;162(1):46-55. doi: 10.1016/j.chest.2022.01.071. Epub 2022 Feb 22.
4
Biologic Therapies for Severe Asthma.重度哮喘的生物疗法
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
5
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.度普利尤单抗可抑制多种特应性、过敏性疾病的 2 型炎症生物标志物。
Clin Exp Allergy. 2021 Jul;51(7):915-931. doi: 10.1111/cea.13954. Epub 2021 Jun 26.
6
Association of common comorbidities with asthma in children: a cross-sectional study.儿童常见合并症与哮喘的关联:一项横断面研究。
Sudan J Paediatr. 2019;19(2):88-92. doi: 10.24911/SJP.106-1544873451.
7
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children.在喘息儿童中,血液嗜酸性粒细胞与特应性相关,而非与组织嗜酸性粒细胞相关。
Allergy. 2020 Jun;75(6):1497-1501. doi: 10.1111/all.14170. Epub 2020 Feb 5.
8
The effects of bronchiectasis on asthma exacerbation.支气管扩张对哮喘急性加重的影响。
Tuberc Respir Dis (Seoul). 2014 Nov;77(5):209-14. doi: 10.4046/trd.2014.77.5.209. Epub 2014 Nov 28.
9
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.国际 ERS/ATS 指南:严重哮喘的定义、评估和治疗。
Eur Respir J. 2014 Feb;43(2):343-73. doi: 10.1183/09031936.00202013. Epub 2013 Dec 12.
10
Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels.根据口服类固醇需求评估哮喘患者中支气管扩张的患病率:免疫球蛋白水平的影响
Biomed Res Int. 2013;2013:109219. doi: 10.1155/2013/109219. Epub 2013 Nov 13.